Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38333
CAS Number:
150915-40-5
Chlorhydrate de tirofiban monohydraté
Purity:
≥ 98 % (HPLC)
Synonym(s):
Chlorhydrate de N- (butylsulfonyl) -O- [4-(4-pipéridinyl)butyl]-L-tyrosine monohydraté
Documents
$359.94 /50 mg
Taille
Request Bulk Quote
Informations sur le produit

Tirofiban hydrochloride monohydrate is a potent antiplatelet agent primarily used in the management of acute coronary syndromes and during percutaneous coronary interventions. This compound functions by inhibiting the glycoprotein IIb/IIIa receptor on platelets, effectively preventing platelet aggregation and thrombus formation. Its rapid onset of action and short half-life make it an ideal choice for acute settings, allowing for quick therapeutic responses in critical situations.

In clinical practice, Tirofiban hydrochloride monohydrate is often utilized in combination with other antithrombotic therapies to enhance patient outcomes during high-risk cardiovascular procedures. Its unique properties, such as high selectivity and efficacy, distinguish it from other agents in the same class, making it a valuable tool for healthcare professionals aiming to improve patient safety and recovery in cardiovascular interventions. Researchers are also exploring its potential in other therapeutic areas, highlighting its versatility and importance in modern medicine.

Numéro CAS 
150915-40-5
Formule moléculaire
C22H36N2O5S · HCl · H2O
Poids moléculaire 
495.08
Point de fusion 
131 - 133 °C
Rotation optique 
-12 à -16 ° (C=1, MeOH)
Informations générales
Numéro CAS 
150915-40-5
Formule moléculaire
C22H36N2O5S · HCl · H2O
Poids moléculaire 
495.08
Point de fusion 
131 - 133 °C
Rotation optique 
-12 à -16 ° (C=1, MeOH)
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Tirofiban hydrochloride monohydrate is widely utilized in research focused on

  • Cardiovascular Medicine: It is primarily used as an antiplatelet agent in the treatment of acute coronary syndromes, helping to prevent blood clots and improve blood flow during critical medical situations.
  • Clinical Trials: Researchers often employ this compound in clinical studies to evaluate its efficacy and safety in various cardiovascular conditions, providing valuable data for future treatments.
  • Pharmaceutical Development: Tirofiban is crucial in the development of new medications aimed at improving heart health, offering a foundation for creating more effective therapies.
  • Laboratory Research: It serves as a model compound in pharmacological studies, allowing scientists to explore the mechanisms of platelet aggregation and the effects of antiplatelet therapies.
  • Emergency Medicine: In emergency settings, it is used to manage patients with heart attacks or unstable angina, significantly enhancing patient outcomes when administered promptly.

Citations